LP
| Title | Published in | Access level | OA Policy | Year | Views | Downloads | |
|---|---|---|---|---|---|---|---|
| Tracing the HIV-1 subtype B mobility in Europe: a phylogeographic approach | Retrovirology | 2009 | 642 | 74 | |||
| Human herpesvirus-6 variant A encephalomyelitis | Neurology | 2008 | 676 | 0 | |||
| New complete genome sequences of human rhinoviruses shed light on their phylogeny and genomic features | BMC genomics | 2007 | 659 | 1,125 | |||
| Transmission of HIV-1 drug resistance in Switzerland: a 10-year molecular epidemiology survey | AIDS | 2007 | 523 | 0 | |||
| HIV viral load monitoring in resource-limited regions: optional or necessary? | Clinical infectious diseases | 2007 | 631 | 1 | |||
| Emergence of HIV-1 drug resistance in previously untreated patients initiating combination antiretroviral treatment: a comparison of different regimen types | Archives of internal medicine | 2007 | 620 | 0 | |||
| Cytomegalovirus quantification in plasma by an automated real-time PCR assay | Journal of clinical virology | 2007 | 665 | 0 | |||
| CD4-guided scheduled treatment interruptions compared with continuous therapy for patients infected with HIV-1: results of the Staccato randomised trial | Lancet | 2006 | 672 | 0 | |||
| Chronic rhinoviral infection in lung transplant recipients | American journal of respiratory and critical care medicine | 2006 | 693 | 0 | |||
| HIV-1 p24 may persist during long-term highly active antiretroviral therapy, increases little during short treatment breaks, and its rebound after treatment stop correlates with CD4(+) T cell loss | Journal of acquired immune deficiency syndromes | 2005 | 604 | 0 | |||
| Characteristics, determinants, and clinical relevance of CD4 T cell recovery to <500 cells/microL in HIV type 1-infected individuals receiving potent antiretroviral therapy | Clinical infectious diseases | 2005 | 596 | 0 | |||
| Long-term efficacy after switch from protease inhibitor-containing highly active antiretroviral therapy to abacavir, lamivudine, and zidovudine | AIDS | 2004 | 76 | 0 | |||
| The incubation period of acute retroviral syndrome as a multistep process: a parametric survival analysis | Journal of acquired immune deficiency syndromes | 2004 | 614 | 0 | |||
| Long-term virological response to multiple sequential regimens of highly active antiretroviral therapy for HIV infection | Antiviral therapy | 2004 | 486 | 0 | |||
| Amplicon sequencing and improved detection of human rhinovirus in respiratory samples | Journal of clinical microbiology | 2004 | 626 | 0 | |||
| Proviral HIV-DNA predicts viral rebound and viral setpoint after structured treatment interruptions | AIDS | 2004 | 634 | 0 | |||
| Infrequent transmission of HIV-1 drug-resistant variants | Antiviral therapy | 2004 | 616 | 0 | |||
| Lower respiratory viral illnesses: improved diagnosis by molecular methods and clinical impact | American journal of respiratory and critical care medicine | 2004 | 617 | 0 | |||
| HIV-1 co/super-infection in intravenous drug users | AIDS | 2004 | 603 | 0 | |||
| Characterization of genotypic determinants in HR-1 and HR-2 gp41 domains in individuals with persistent HIV viraemia under T-20 | AIDS | 2004 | 821 | 0 | |||
| Quantifiable cytotoxic T lymphocyte responses and HLA-related risk of progression to AIDS | Proceedings of the National Academy of Sciences of the United States of America | 2004 | 614 | 0 | |||
| The density of coreceptors at the surface of CD4+ T cells contributes to the extent of human immunodeficiency virus type 1 viral replication-mediated T cell death | AIDS research and human retroviruses | 2004 | 542 | 0 | |||
| A controlled trial of granulocyte macrophage-colony stimulating factor during interruption of HAART | AIDS | 2003 | 547 | 0 | |||
| Monitoring of cytomegalovirus infection in solid-organ transplant recipients by an ultrasensitive plasma PCR assay | Journal of clinical microbiology | 2003 | 630 | 345 | |||
| Travel and the spread of HIV-1 genetic variants | Lancet. Infectious diseases | 2003 | 601 | 0 | |||
| A prospective trial of structured treatment interruptions in human immunodeficiency virus infection | Archives of internal medicine | 2003 | 626 | 0 | |||
| Failures of 1 week on, 1 week off antiretroviral therapies in a randomized trial | AIDS | 2003 | 622 | 0 | |||
| CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study | Archives of internal medicine | 2003 | 578 | 0 | |||
| Brief report: incubation and duration of specific symptoms at acute retroviral syndrome as independent predictors of progression to AIDS | Journal of acquired immune deficiency syndromes | 2003 | 665 | 0 | |||
| Drug resistance mutations during structured treatment interruptions | Antiviral therapy | 2003 | 557 | 0 | |||
| Analysis of HIV-1- and CMV-specific memory CD4 T-cell responses during primary and chronic infection | Blood | 2002 | 620 | 0 | |||
| Residual HIV-specific CD4 and CD8 T cell frequencies after prolonged antiretroviral therapy reflect pretreatment plasma virus load | AIDS | 2002 | 525 | 0 | |||
| Stimulation of HIV-specific cellular immunity by structured treatment interruption fails to enhance viral control in chronic HIV infection | Proceedings of the National Academy of Sciences of the United States of America | 2002 | 587 | 0 | |||
| Improved monitoring of cytomegalovirus infection after allogeneic hematopoietic stem cell transplantation by an ultrasensitive plasma DNA PCR assay | Journal of clinical microbiology | 2002 | 660 | 0 | |||
| The CD4 cell count 3 months after acute retroviral syndrome is associated with the presence of AIDS in the source individual | AIDS | 2002 | 574 | 0 | |||
| Clinical features of acute retroviral syndrome differ by route of infection but not by gender and age | Journal of acquired immune deficiency syndromes | 2002 | 622 | 0 | |||
| Intermittent and sustained low-level HIV viral rebound in patients receiving potent antiretroviral therapy | AIDS | 2002 | 572 | 0 | |||
| A randomized trial of simplified maintenance therapy with abacavir, lamivudine, and zidovudine in human immunodeficiency virus infection | The Journal of infectious diseases | 2002 | 651 | 0 | |||
| A patient with HIV-1 superinfection | The New England journal of medicine | 2002 | 573 | 0 | |||
| Immunological and virological effects of ribavirin in hepatitis C after liver transplantation | Transplantation | 2002 | 610 | 0 | |||
| Acute HIV infection: impact on the spread of HIV and transmission of drug resistance | AIDS | 2001 | 522 | 0 | |||
| Nosocomial outbreak of multiple bloodborne viral infections | The Journal of infectious diseases | 2001 | 708 | 281 | |||
| Time of initiation of antiretroviral therapy: impact on HIV-1 viraemia. The Swiss HIV Cohort Study | AIDS | 2000 | 537 | 0 | |||
| Clinical features of acute HIV-1 infection: zidovudine-resistant isolates compared with zidovudine-sensitive isolates | AIDS | 2000 | 464 | 0 | |||
| Incubation time of acute human immunodeficiency virus (HIV) infection and duration of acute HIV infection are independent prognostic factors of progression to AIDS | The Journal of infectious diseases | 2000 | 683 | 0 | |||
| Long-term hydroxyurea in combination with didanosine and stavudine for the treatment of HIV-1 infection. Swiss HIV Cohort Study | AIDS | 2000 | 495 | 0 | |||
| Comparison of clinical features, CD4 and CD8 responses among patients with acute HIV-1 infection from Geneva, Seattle and Sydney | AIDS | 2000 | 594 | 0 | |||
| Decay of cell-associated HIV-1 DNA correlates with residual replication in patients treated during acute HIV-1 infection | AIDS | 2000 | 570 | 0 | |||
| Clinical progression, survival, and immune recovery during antiretroviral therapy in patients with HIV-1 and hepatitis C virus coinfection: the Swiss HIV Cohort Study | Lancet | 2000 | 519 | 0 | |||
| Prophylaxie post exposition au VIH: eligibilite des patients récemment infectés par voie sexuelle | Schweizerische medizinische Wochenschrift | 1999 | 738 | 0 | |||
| Cell-associated HIV-1 RNA in blood as indicator of virus load in lymph nodes. The Swiss HIV Cohort Study | The Journal of infectious diseases | 1999 | 580 | 0 | |||
| Comprehensive classification of symptoms and signs reported among 218 patients with acute HIV-1 infection | Journal of acquired immune deficiency syndromes | 1999 | 536 | 0 | |||
| Impact of drug resistance mutations on virologic response to salvage therapy. Swiss HIV Cohort Study | AIDS | 1999 | 573 | 0 | |||
| A placebo-controlled trial of didanosine plus stavudine, with and without hydroxyurea, for HIV infection. The Swiss HIV Cohort Study | AIDS | 1998 | 509 | 0 | |||
| A randomized double-blind controlled study of 6 months of oral nutritional supplementation with arginine and omega-3 fatty acids in HIV-infected patients. Swiss HIV Cohort Study | AIDS | 1998 | 644 | 0 | |||
| Detection of intrahepatic hepatitis C virus replication by strand-specific semi-quantitative RT-PCR: preliminary application to the liver transplantation model | Journal of hepatology | 1998 | 555 | 0 | |||
| Didanosine plus stavudine with or without hydroxyurea in HIV-1-infected patients: 1 year follow-up. Swiss HIV Cohort Study | Antiviral therapy | 1998 | 506 | 0 | |||
| Turnover of CD4+ and CD8+ T lymphocytes in HIV-1 infection as measured by Ki-67 antigen | The Journal of experimental medicine | 1998 | 518 | 0 | |||
| Severity and prognosis of acute human immunodeficiency virus type 1 illness: a dose-response relationship | Clinical infectious diseases | 1998 | 576 | 0 | |||
| A critical assessment of the prognostic value of HIV-1 RNA levels and CD4+ cell counts in HIV-infected patients. The Swiss HIV Cohort Study | Archives of internal medicine | 1998 | 545 | 0 | |||
| Virus burden in lymph nodes and blood of subjects with primary human immunodeficiency virus type 1 infection on bitherapy | The Journal of infectious diseases | 1998 | 561 | 0 | |||
| Switch to unusual amino acids at codon 215 of the human immunodeficiency virus type 1 reverse transcriptase gene in seroconvertors infected with zidovudine-resistant variants | Journal of virology | 1998 | 568 | 0 | |||
| Prevalence and incidence rate of HIV, hepatitis B and C among drug users on methadone maintenance treatment in Geneva between 1988 and 1995 | AIDS | 1998 | 674 | 2 | |||
| IgM anti-hepatitis C virus core antibodies as marker of recurrent hepatitis C after liver transplantation | Journal of medical virology | 1998 | 836 | 0 | |||
| Toxicity, efficacy, plasma drug concentrations and protease mutations in patients with advanced HIV infection treated with ritonavir plus saquinavir. Swiss HIV Cohort Study | AIDS | 1997 | 536 | 0 | |||
| Adding saquinavir to stavudine in patients with advanced HIV-1 infection | AIDS | 1997 | 524 | 0 | |||
| Genetic polymorphism of CCR5 gene and HIV disease: the heterozygous (CCR5/delta ccr5) genotype is neither essential nor sufficient for protection against disease progression. Swiss HIV Cohort | European Journal of Immunology | 1997 | 663 | 0 | |||
| Zidovudine plus didanosine in primary HIV-1 infection | Antiviral therapy | 1997 | 591 | 0 | |||
| Acute human immunodeficiency virus type 1 disease as a mononucleosis-like illness: is the diagnosis too restrictive? | Clinical infectious diseases | 1997 | 592 | 0 | |||
| Chemotherapy for AIDS-related malignancies does not increase HIV viraemia | AIDS | 1997 | 510 | 0 | |||
| Prévalence de la transmission de virus résistant à la zidovudine en Suisse. L'étude suisse de cohorte VIH | Schweizerische medizinische Wochenschrift | 1996 | 566 | 0 | |||
| Combined therapy with zidovudine and L-697,661 in primary HIV infection | AIDS | 1996 | 587 | 0 | |||
| Predictive value of codon 215 reverse transcriptase mutation on the efficacy of didanosine in HIV-infected, zidovudine-experienced patients | Antiviral therapy | 1996 | 458 | 0 | |||
| Combination therapy in primary HIV infection | Antiviral research | 1996 | 587 | 0 | |||
| Prognostic value of viremia in patients with long-standing human immunodeficiency virus infection. Swiss HIV Cohort Study Group | The Journal of infectious diseases | 1996 | 573 | 0 | |||
| The risk of HIV transmission by screened blood | The New England journal of medicine | 1996 | 573 | 0 | |||
| Early and prolonged decrease of viremia in HIV-1-infected patients treated with didanosine | Journal of acquired immune deficiency syndromes and human retrovirology | 1995 | 627 | 0 | |||
| Response of HIV RNA to didanosine as a predictive marker of survival | AIDS | 1995 | 660 | 0 | |||
| Toxoplasma encephalitis in patients with the acquired immunodeficiency syndrome | Medicine | 1992 | 608 | 0 | |||
| Absence of chronic human immunodeficiency virus infection without seroconversion in intravenous drug users: a prospective and retrospective study | The Journal of infectious diseases | 1991 | 550 | 0 | |||
| Behavioural changes in intravenous drug users in Geneva: rise and fall of HIV infection, 1980-1989 | AIDS | 1990 | 555 | 0 | |||
| A controlled study of early neurologic abnormalities in men with asymptomatic human immunodeficiency virus infection | The New England journal of medicine | 1990 | 620 | 0 | |||
| Activation polyclonale B associee a l'infection par le virus d'immunodeficience humaine (VIH) | Schweizerische medizinische Wochenschrift | 1987 | 766 | 0 | |||
| Meningococcemia in a patient with acquired complement deficiency and myeloma | The New England journal of medicine | 1984 | 654 | 0 |
